Trial
NCT04348656
CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Hamilton Health Sciences Corporation
Collaborators
Canadian Blood Services; Héma-Québec; University of Toronto; Université de Montréal; Weill Medical College of Cornell University; New York Blood Center
Condition
COVID-19
Intervention
Convalescent plasma
Why stopped
Study was terminated after the planned interim analysis as the pre-defined futility threshold was met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-03